Regarding dendritic cell approaches to cancer. Just because it’s taken a long time to prove by the requirements imposed by the current drug approval process in no way means it’s obsolete in some way. The one doesn’t logically follow the other.
From a theoretical perspective, given what we know about the role of DCs in the immune system, it seems like one of the best approaches to focus on to try to get to work. JMO